KRAS and lung carcinoma: The western blot assay showed that BP-1-102 alone increased the protein levels of p-MEK and p-ERK in KRAS mutant lung cancer cells compared with cells without treatment, whereas in wild-type cells, BP-1-102 alone had little effect on their protein levels (Figure 4A, 4B).